View Older Stories View More Recent Stories

Aug 8, 2022 09:39AM Athersys Announces Favorable Preclinical Results for MultiStem® Treatment in Defense Department Radiation Countermeasure Study and Upcoming Webinar to Review Preclinical Research With MultiStem Acros
Aug 4, 2022 08:01AM Athersys (ATHX) Appoints Kasey Rosado as Interim CFO
Aug 4, 2022 08:00AM Athersys Appoints Kasey Rosado as Interim Chief Financial Officer
Jul 26, 2022 10:00AM Athersys to Host Second Quarter Financial Results Call
Jul 8, 2022 07:30AM Athersys (ATHX) and Aspire Capital Fund Terminate Relationship
Jul 8, 2022 07:30AM Athersys and Aspire Capital Fund Terminate Relationship
Jun 21, 2022 06:00AM Athersys Announces Board of Directors Slate for 2022 Annual Meeting of Stockholders and Director Departures
Jun 9, 2022 07:03AM Athersys (ATHX) Postpones Annual Meeting of Stockholders
Jun 9, 2022 07:00AM Athersys Postpones Annual Meeting of Stockholders
Jun 8, 2022 02:45PM Athersys Hosting KOL Panel Event to Discuss TREASURE Data
Jun 2, 2022 04:05PM Athersys Announces Restructuring and Management Changes to Focus on Its Existing Clinical Programs
May 20, 2022 05:53AM Athersys (ATHX) Announces That HEALIOS Reports Topline Data From the TREASURE Multistem Ischemic Stroke Study
May 20, 2022 03:00AM Athersys Announces That Its Partner, HEALIOS K.K., Reported Topline Data From the TREASURE Multistem Ischemic Stroke Study
May 13, 2022 08:00AM Athersys to Participate in the H.C. Wainwright Global Investment Conference
May 6, 2022 08:00AM Athersys Reports First Quarter 2022 Results
May 2, 2022 09:00AM Athersys to Participate in the Bank of America Securities 2022 Global Healthcare Conference
Apr 29, 2022 09:00AM Athersys to Announce First Quarter Financial Results on May 6
Apr 4, 2022 07:17AM Athersys (ATHX) Reports That Its Partner, HEALIOS K.K., Provides Updates on MultiStem® Clinical Programs in Japan
Apr 4, 2022 06:00AM  Athersys Reports That Its Partner, HEALIOS K.K., Provides Updates on MultiStem® Clinical Programs in Japan
Apr 1, 2022 04:46PM Athersys to Participate in Two Upcoming Investor Conferences
Mar 15, 2022 04:05PM Athersys Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights
Feb 17, 2022 04:30PM Athersys Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Feb 15, 2022 08:00AM Athersys to Host Year-End 2021 Financial Results Call
Jan 26, 2022 08:00AM Athersys to Host a Virtual Presentation on Its MultiStem® Programs
Jan 21, 2022 05:12AM Athersys (ATHX) Appoints Daniel A. Camardo as CEO
Jan 20, 2022 06:00PM Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer
Nov 30, 2021 06:03AM Athersys (ATHX) Reports Publication of Data from Placebo-Controlled Clinical Trial Evaluating MultiStem Cell Therapy for Acute Respiratory Distress Syndrome
Nov 30, 2021 06:00AM Report of Placebo-Controlled Clinical Trial Evaluating MultiStem® Cell Therapy for Acute Respiratory Distress Syndrome Published in Intensive Care Medicine
Nov 15, 2021 04:05PM Athersys Reports Third Quarter 2021 Results and Provides Corporate Update
Nov 12, 2021 06:00AM Athersys Reports Updates on Timing for Japan ARDS and Stroke Programs From Healios K.K.
Oct 18, 2021 10:07AM Athersys to Host Third Quarter Financial Results Call
Sep 28, 2021 07:00AM Athersys to Present at 2021 Cell & Gene Meeting on the Mesa Hybrid Conference
Aug 10, 2021 09:17AM Athersys Partner HEALIOS K.K. Completes Enrollment in the TREASURE Study of MultiStem Treatment for Ischemic Stroke
Aug 9, 2021 04:05PM Athersys Reports Second Quarter 2021 Results
Aug 6, 2021 06:00AM Athersys Partner HEALIOS K.K. Announces Positive Topline Results of MultiStem for Acute Respiratory Distress Syndrome in the ONE-BRIDGE Study
Aug 5, 2021 04:36PM Athersys and Healios K.K. Announce Advancement of Their MultiStem Commercial Partnership
Jul 13, 2021 10:30AM Athersys to Host Second Quarter Financial Results Call
Jun 30, 2021 06:00AM New Publication Provides Further Clarity of MultiStem's Mechanism of Action on Modulating the Inflammatory Response in Critical Care Indications
May 6, 2021 04:05PM Athersys Reports First Quarter 2021 Results
Apr 28, 2021 01:00PM Athersys to Present at the Bank of America Virtual Healthcare Conference on May 12
Apr 13, 2021 07:00AM Athersys to Host First Quarter Financial Results Call
Apr 1, 2021 07:00AM Athersys to Present at the Needham Virtual Healthcare Conference on April 14
Mar 31, 2021 06:00AM Athersys Reports That Healios Has Completed Enrollment in the ONE-BRIDGE Study of MultiStem® for Acute Respiratory Distress Syndrome in Japan
Mar 25, 2021 04:05PM Athersys Announces Financial Results for Fourth Quarter and Full Year 2020
Mar 2, 2021 07:00AM Athersys to Host Year-End 2020 Financial Results Call
Feb 16, 2021 07:51AM Athersys (ATHX) Announces Cooperation Agreement With HEALIOS K.K.
Feb 16, 2021 07:50AM Athersys Announces Cooperation Agreement With HEALIOS K.K.
Feb 16, 2021 07:21AM Athersys (ATHX) Announces CEO Transition
Feb 16, 2021 07:00AM Athersys Announces CEO Transition
Jan 28, 2021 06:00AM Athersys to Host a Virtual Investor Day
View More Recent Stories View Older Stories